These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage. Kurata T, Kametaka S, Ohta Y, Morimoto N, Deguchi S, Deguchi K, Ikeda Y, Takao Y, Ohta T, Manabe Y, Sato S, Abe K. Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889 [Abstract] [Full Text] [Related]
35. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy. Eraslan C, Acarer A, Guneyli S, Akyuz E, Aydin E, Colakoglu Z, Kitis O, Calli MC. Neurol Res; 2019 Feb 15; 41(2):110-117. PubMed ID: 30373485 [Abstract] [Full Text] [Related]
36. Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy. Reginold W, Lang AE, Marras C, Heyn C, Alharbi M, Mikulis DJ. Parkinsonism Relat Disord; 2014 Feb 15; 20(2):222-5. PubMed ID: 24239142 [Abstract] [Full Text] [Related]
39. Higher prevalence of idiopathic normal pressure hydrocephalus-like MRI features in progressive supranuclear palsy: An imaging reminder of atypical parkinsonism. Fu MH, Huang CC, Wu KLH, Chen YF, Kung YC, Lee CC, Liu JS, Lan MY, Chang YY. Brain Behav; 2023 Feb 15; 13(2):e2884. PubMed ID: 36635882 [Abstract] [Full Text] [Related]
40. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Massey LA, Micallef C, Paviour DC, O'Sullivan SS, Ling H, Williams DR, Kallis C, Holton JL, Revesz T, Burn DJ, Yousry T, Lees AJ, Fox NC, Jäger HR. Mov Disord; 2012 Dec 15; 27(14):1754-62. PubMed ID: 22488922 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]